Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
[ad_1] Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market debut on Friday, after going public under the ticker symbol “TEM.” Tempus AI priced 11.1 million shares at $37 apiece…